Search research articles
Contact Us
Filters
Showing results (311-320 of 436) with videos related to
Page
of 44
Sort By:
Cancer
|
April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemia
H M Kantarjian, D Dixon, M J Keating, et al.
Leukemia & Lymphoma
|
October 1, 1996
Hodgkin's disease variant of Richter's syndrome: experience at a single institution
L Fayad, L E Robertson, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1986
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis
S J Iacoboni, W Plunkett, H M Kantarjian, et al.
Cancer
|
August 15, 1986
The association of specific "favorable" cytogenetic abnormalities with secondary leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Leukemia Research
|
January 1, 1987
Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia
M J Keating, A Cork, Y Broach, et al.
Cancer
|
October 15, 1987
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron
R S Walters, H M Kantarjian, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 1999
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture
H M Kantarjian, M Talpaz, S O'Brien, et al.
Blood
|
March 1, 1980
Pretreatment flow cytometry of DNA content in adult acute leukemia
G M Dosik, B Barlogie, T L Smith, et al.
Leukemia & Lymphoma
|
May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis
L E Robertson, R Hall, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features
H M Kantarjian, M J Keating, R S Walters, et al.
Page
of 44
Search research articles
Search
Showing results (311-320 of 436) with videos related to
Sort By:
Page
of 44
Cancer
|
April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemia
H M Kantarjian, D Dixon, M J Keating, et al.
Leukemia & Lymphoma
|
October 1, 1996
Hodgkin's disease variant of Richter's syndrome: experience at a single institution
L Fayad, L E Robertson, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1986
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis
S J Iacoboni, W Plunkett, H M Kantarjian, et al.
Cancer
|
August 15, 1986
The association of specific "favorable" cytogenetic abnormalities with secondary leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Leukemia Research
|
January 1, 1987
Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia
M J Keating, A Cork, Y Broach, et al.
Cancer
|
October 15, 1987
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron
R S Walters, H M Kantarjian, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 1999
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture
H M Kantarjian, M Talpaz, S O'Brien, et al.
Blood
|
March 1, 1980
Pretreatment flow cytometry of DNA content in adult acute leukemia
G M Dosik, B Barlogie, T L Smith, et al.
Leukemia & Lymphoma
|
May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis
L E Robertson, R Hall, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features
H M Kantarjian, M J Keating, R S Walters, et al.
Page
of 44